NCT01119404|Unknown
Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis
HMS-02
Loading search results
HMS-02
Sponsor study identifier
Secondary identifiers
OTHER · Ethics Committee
observational
300
1 country
4
Study Start
June 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Mechanisms that link metabolic syndrome to atherosclerosis are incompletely understood. As a part of Hämeenlinna Metabolic Syndrome Research Program (HMS) surrogate indicators for atherosclerosis are studied in 120 men with metabolic syndrome, 120 men with coronary heart disease and 80 physically active controls and in different settings.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2003
Date type not reportedThis date has not been verified as actual or estimated.
May 6, 2010
Actual (reported)May 7, 2010
Actual (reported)June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
120 men with metabolic syndrome
120 men with angiographically verified CHD
80 physically active men
Primary care clinic
Linnan Klinikka
Hämeenlinna, 13100, Finland
Mehiläinen Hämeenlinna
Hämeenlinna, 13100, Finland
Central Hospital of Kanta-Häme
Hämeenlinna, 13530, Finland
Saarinen HJ, Lahtela J, Mahonen P, Palomaki A; Hameenlinna Metabolic Syndrome Research Program Study Group. The association between inflammation, arterial stiffness, oxidized LDL and cardiovascular disease in Finnish men with metabolic syndrome - a 15-year follow-up study. BMC Cardiovasc Disord. 2024 Mar 15;24(1):162. doi: 10.1186/s12872-024-03818-x.
Pohjantahti-Maaroos H, Palomaki A, Kankkunen P, Husgafvel S, Knuth T, Vesterinen K, Oksanen K. Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models. Ann Med. 2012 Aug;44(5):503-12. doi: 10.3109/07853890.2011.590520. Epub 2011 Jul 4.
serum, EDTA plasma, citrate plasma
Ari K Palomäki, MD PhD
Central Hospital of Kanta-Häme
Kalevi Oksanen, MD PhD
Central Hospital of Kanta-Häme
First Submitted
May 6, 2010
First Posted
May 7, 2010
Study Start
June 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
Contact the study team to confirm eligibility.
Finnish Red Cross Blood Transfusion Service
Helsinki, 00310, Finland
Pohjantahti-Maaroos H, Palomaki A, Hartikainen J. Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis. BMC Cardiovasc Disord. 2011 Jun 27;11:36. doi: 10.1186/1471-2261-11-36.
Study Completion
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 11, 2010
Record last verified: 2010-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: